Parexel, headquartered in Waltham, Massachusetts, United States, is a leading global biopharmaceutical services provider. Founded in 1982 by Josef H. Parexel offers a wide range of products and services to support the development and commercialization of new medical treatments and therapies.

Its core offerings include clinical trials management, regulatory consulting, data analytics, and market access services. The company partners with pharmaceutical, biotech, and medical device companies, as well as government organizations, to provide these services throughout the drug development lifecycle. Operating on a global scale, Parexel has established a strong presence in key markets worldwide.

It has subsidiaries and offices in more than 50 countries, including Europe, Asia-Pacific, Latin America, and the Middle East. The company has also entered into strategic partnerships and joint ventures to expand its reach. Notably, Parexel has a joint venture with Peking University Clinical Research Institute (PU-CRI) in China, which allows it to tap into the expanding Chinese pharmaceutical market.

In terms of market position, Parexel is a leader in the CRO industry. It consistently ranks among the top CRO companies globally and has a significant market share. Its strong reputation, extensive network of clients, and comprehensive service offerings have contributed to its market dominance.

Over the years, Parexel has achieved numerous milestones and witnessed significant events. In 2017, it was acquired by the private equity group Pamplona Capital Management in a deal worth $5 billion. This acquisition has allowed Parexel to pursue its strategic growth initiatives and expand its capabilities.

As of the latest available information, Parexel continues to operate as a global biopharmaceutical services provider. It remains committed to driving innovation, advancing clinical research, and improving patient outcomes. The company continues to invest in technology, data analytics, and strategic partnerships to stay at the forefront of the industry.

In conclusion, Parexel is a renowned biopharmaceutical services provider headquartered in the United States. It offers an array of products and services globally, serving the needs of the pharmaceutical and biotech industries. With its strong market position, strategic partnerships, and commitment to advancing medical research, Parexel remains a key player in the healthcare industry